Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 33475 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 94771 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 113297 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 175677 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 256132 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 403031 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 503026 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 682608 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 898190 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 1209034 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 1518948 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 1951407 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 3386292 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (M-H)- | 5387791 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 27096 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 31266 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 35736 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 40033 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 40566 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 42174 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 44009 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 46192 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 47284 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 48014 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 48473 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 49230 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 55124 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+H)+ | 55652 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 36400 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 37590 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 40953 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 42898 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 44565 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 48483 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 51193 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 54089 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 60454 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 64973 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 68085 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 71358 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | 101232 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEIC ACID (M+NA)+ | Peak area normalized | female | diabetic | no neuropathy |